XML 14 R21.htm IDEA: XBRL DOCUMENT v3.19.3

Note 14 - Segment Information

9 Months Ended

Sep. 28, 2019

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

1 4 . Segment Information

The Company follows “Disclosures about Segments of an Enterprise and Related Information,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note

1

to the Company’s Consolidated Financial Statements included in its Annual Report on Form

10

-K for the year ended

December 29, 2018).

Segment operating income includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company’s management system:

Thirteen Week Period Ended September 28, 2019		Engineering				Specialty Health Care				Information Technology				Corporate				Total
Revenue		$	15,140			$	16,765			$	8,345			$	-			$	40,250
Cost of services			10,984				12,795				5,856				-				29,635
Gross profit			4,156				3,970				2,489				-				10,615
Selling, general and administrative			2,996				4,205				2,297				-				9,498
Depreciation and amortization			293				74				19				-				386
Operating income (loss)		$	867			$	(309	)		$	173			$	-			$	731
Total assets as of September 28, 2019		$	53,639			$	25,822			$	7,773			$	4,506			$	91,740
Capital expenditures		$	(11	)		$	2			$	19			$	53			$	63

Thirteen Week Period Ended September 29, 2018		Engineering				Specialty Health Care				Information Technology				Corporate				Total
Revenue		$	19,424			$	15,106			$	8,029			$	-			$	42,559
Cost of services			14,049				11,665				5,857				-				31,571
Gross profit			5,375				3,441				2,172				-				10,988
Selling, general and administrative			3,780				3,648				1,984				-				9,412
Depreciation and amortization			236				85				23				-				344
Operating income (loss)		$	1,359			$	(292	)		$	165			$	-			$	1,232
Total assets as of September 29, 2018		$	40,643			$	18,874			$	7,110			$	6,801			$	73,428
Capital expenditures		$	465			$	151			$	90			$	110			$	816

Thirty-Nine Week Period Ended September 28, 2019		Engineering				Specialty Health Care				Information Technology				Corporate				Total
Revenue		$	52,778			$	64,305			$	25,467			$	-			$	142,550
Cost of services			38,666				49,395				18,554				-				106,615
Gross profit			14,112				14,910				6,913				-				35,935
Selling, general and administrative			10,486				12,990				6,689				-				30,165
Depreciation and amortization			879				250				62				-				1,191
Operating income		$	2,747			$	1,670			$	162			$	-			$	4,579
Total assets as of September 28, 2019		$	53,639			$	25,822			$	7,773			$	4,506			$	91,740
Capital expenditures		$	76			$	107			$	36			$	82			$	301

Thirty-Nine Week Period Ended September 29, 2018		Engineering				Specialty Health Care				Information Technology				Corporate				Total
Revenue		$	62,412			$	60,599			$	22,070			$	-			$	145,081
Cost of services			45,706				46,822				16,275				-				108,803
Gross profit			16,706				13,777				5,795				-				36,278
Selling, general and administrative			12,006				12,255				5,648				-				29,909
Depreciation and amortization			785				294				77				-				1,156
Severance, professional fees and other charges			-				-				-				1,371				1,371
Operating income (loss)		$	3,915			$	1,228			$	70			$	(1,371	)		$	3,842
Total assets as of September 29, 2018		$	40,643			$	18,874			$	7,110			$	6,801			$	73,428
Capital expenditures		$	856			$	207			$	108			$	243			$	1,414

The Company derives a majority of its revenue from offices in the United States. Revenue reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Serbia. Revenue by geographic area for the

thirteen

and

thirty-nine

week periods ended

September 28, 2019

and

September 29, 2018

are as follows:

		Thirteen Week Periods Ended								Thirty-Nine Week Periods Ended
		September 28, 2019				September 29, 2018				September 28, 2019				September 29, 2018
Revenue
U. S.		$	34,810			$	34,729			$	124,356			$	118,364
Canada			3,682				6,308				12,770				21,942
Puerto Rico			1,215				1,113				3,627				3,142
Serbia			543				409				1,797				1,633
		$	40,250			$	42,559			$	142,550			$	145,081

Total assets by geographic area as of the reported periods are as follows:

		September 28, 2019				December 29, 2018
Total assets
U. S.		$	72,814			$	61,417
Canada			12,316				14,230
Puerto Rico			1,997				1,954
Serbia			4,616				3,909
		$	91,740			$	81,510

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureTextBlockAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Name:	us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration